Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza

Abstract  A live attenuated influenza vaccine (LAIV) is currently approved in the United States for the prevention of influenza in individuals 2–49 years of age. This article summarizes the available data describing the safety and efficacy of LAIV for the prevention of influenza in both children and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambrose, Christopher S., Luke, Catherine, Coelingh, Kathleen
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710797/
https://www.ncbi.nlm.nih.gov/pubmed/19453395
http://dx.doi.org/10.1111/j.1750-2659.2008.00056.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710797/
https://www.ncbi.nlm.nih.gov/pubmed/19453395
http://dx.doi.org/10.1111/j.1750-2659.2008.00056.x

Ejemplares similares